COMSTOCK HOLDING COMPANIES (CHCI) Fundamental Analysis & Valuation

NASDAQ:CHCI • US2056842022

Current stock price

15.36 USD
-0.44 (-2.78%)
Last:

This CHCI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. CHCI Profitability Analysis

1.1 Basic Checks

  • CHCI had positive earnings in the past year.
  • CHCI had a positive operating cash flow in the past year.
  • In the past 5 years CHCI has always been profitable.
  • Each year in the past 5 years CHCI had a positive operating cash flow.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M

1.2 Ratios

  • CHCI's Return On Assets of 20.07% is amongst the best of the industry. CHCI outperforms 100.00% of its industry peers.
  • CHCI has a better Return On Equity (24.37%) than 100.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.29%, CHCI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • CHCI had an Average Return On Invested Capital over the past 3 years of 16.02%. This is significantly above the industry average of 5.73%.
Industry RankSector Rank
ROA 20.07%
ROE 24.37%
ROIC 13.29%
ROA(3y)19.37%
ROA(5y)22.28%
ROE(3y)24.36%
ROE(5y)31.87%
ROIC(3y)16.02%
ROIC(5y)16.51%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 27.12%, CHCI belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CHCI has grown nicely.
  • With an excellent Operating Margin value of 18.98%, CHCI belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • CHCI's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CHCI (23.51%) is comparable to the rest of the industry.
  • CHCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.98%
PM (TTM) 27.12%
GM 23.51%
OM growth 3Y-2.31%
OM growth 5Y9.6%
PM growth 3Y4.28%
PM growth 5Y23.78%
GM growth 3Y-2.27%
GM growth 5Y5.75%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

8

2. CHCI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHCI is creating some value.
  • CHCI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CHCI has been increased compared to 5 years ago.
  • There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 5.98 indicates that CHCI is not in any danger for bankruptcy at the moment.
  • CHCI has a Altman-Z score of 5.98. This is amongst the best in the industry. CHCI outperforms 82.54% of its industry peers.
  • There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.98
ROIC/WACC1.47
WACC9.03%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • CHCI has a Current Ratio of 3.79. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
  • CHCI's Current ratio of 3.79 is fine compared to the rest of the industry. CHCI outperforms 79.37% of its industry peers.
  • A Quick Ratio of 3.79 indicates that CHCI has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.79, CHCI belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

5

3. CHCI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.10% over the past year.
  • Measured over the past years, CHCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.47% on average per year.
  • CHCI shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.55%.
  • The Revenue has been growing by 22.81% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.1%
EPS 3Y18.85%
EPS 5Y45.47%
EPS Q2Q%29.72%
Revenue 1Y (TTM)22.55%
Revenue growth 3Y16.95%
Revenue growth 5Y22.81%
Sales Q2Q%41.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

5

4. CHCI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.48, the valuation of CHCI can be described as reasonable.
  • Based on the Price/Earnings ratio, CHCI is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 25.54, CHCI is valued rather cheaply.
Industry RankSector Rank
PE 9.48
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 84.13% of the companies in the same industry are more expensive than CHCI, based on the Enterprise Value to EBITDA ratio.
  • CHCI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHCI is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.09
EV/EBITDA 10.47
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • CHCI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CHCI Dividend Analysis

5.1 Amount

  • CHCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CHCI Fundamentals: All Metrics, Ratios and Statistics

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (3/23/2026, 4:30:00 PM)

15.36

-0.44 (-2.78%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-19
Earnings (Next)05-11
Inst Owners13.15%
Inst Owner Change11.71%
Ins Owners66.06%
Ins Owner Change1.21%
Market Cap154.98M
Revenue(TTM)62.86M
Net Income(TTM)17.05M
Analysts0
Price TargetN/A
Short Float %0.86%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.48
Fwd PE N/A
P/S 2.47
P/FCF 35.09
P/OCF 32.31
P/B 2.22
P/tB 2.22
EV/EBITDA 10.47
EPS(TTM)1.62
EY10.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.44
FCFY2.85%
OCF(TTM)0.48
OCFY3.1%
SpS6.23
BVpS6.93
TBVpS6.92
PEG (NY)N/A
PEG (5Y)0.21
Graham Number15.9
Profitability
Industry RankSector Rank
ROA 20.07%
ROE 24.37%
ROCE 16.82%
ROIC 13.29%
ROICexc 23.77%
ROICexgc 23.92%
OM 18.98%
PM (TTM) 27.12%
GM 23.51%
FCFM 7.03%
ROA(3y)19.37%
ROA(5y)22.28%
ROE(3y)24.36%
ROE(5y)31.87%
ROIC(3y)16.02%
ROIC(5y)16.51%
ROICexc(3y)32.21%
ROICexc(5y)31.65%
ROICexgc(3y)32.48%
ROICexgc(5y)31.85%
ROCE(3y)20.28%
ROCE(5y)20.89%
ROICexgc growth 3Y-13.5%
ROICexgc growth 5Y-1.9%
ROICexc growth 3Y-13.51%
ROICexc growth 5Y1.78%
OM growth 3Y-2.31%
OM growth 5Y9.6%
PM growth 3Y4.28%
PM growth 5Y23.78%
GM growth 3Y-2.27%
GM growth 5Y5.75%
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 124.18%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 39.2%
Profit Quality 25.9%
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z 5.98
F-Score4
WACC9.03%
ROIC/WACC1.47
Cap/Depr(3y)120.85%
Cap/Depr(5y)172.51%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.81%
Profit Quality(3y)69.73%
Profit Quality(5y)68.97%
High Growth Momentum
Growth
EPS 1Y (TTM)16.1%
EPS 3Y18.85%
EPS 5Y45.47%
EPS Q2Q%29.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.55%
Revenue growth 3Y16.95%
Revenue growth 5Y22.81%
Sales Q2Q%41.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.97%
EBIT growth 3Y14.25%
EBIT growth 5Y34.6%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.15%
FCF growth 3Y-16.18%
FCF growth 5Y6%
OCF growth 1Y-55.06%
OCF growth 3Y-16.02%
OCF growth 5Y7.13%

COMSTOCK HOLDING COMPANIES / CHCI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for COMSTOCK HOLDING COMPANIES?

ChartMill assigns a fundamental rating of 7 / 10 to CHCI.


What is the valuation status of COMSTOCK HOLDING COMPANIES (CHCI) stock?

ChartMill assigns a valuation rating of 5 / 10 to COMSTOCK HOLDING COMPANIES (CHCI). This can be considered as Fairly Valued.


What is the profitability of CHCI stock?

COMSTOCK HOLDING COMPANIES (CHCI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of COMSTOCK HOLDING COMPANIES (CHCI) stock?

The Price/Earnings (PE) ratio for COMSTOCK HOLDING COMPANIES (CHCI) is 9.48 and the Price/Book (PB) ratio is 2.22.


How financially healthy is COMSTOCK HOLDING COMPANIES?

The financial health rating of COMSTOCK HOLDING COMPANIES (CHCI) is 8 / 10.